Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Esophagogastric Junction.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01726452
What this trial is testing

NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)

Who this might be right for
Adenocarcinoma of the OesophagusAdenocarcinoma of the Oesophago-gastric JunctionOesophageal Tumours+2 more
Cancer Trials Ireland 377
Large-scale testing (Phase 3)Study completedNCT01196390
What this trial is testing

Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal AdenocarcinomaGastroesophageal Junction AdenocarcinomaStage IB Esophageal Cancer AJCC v7+4 more
National Cancer Institute (NCI) 203
Testing effectiveness (Phase 2)Active Not RecruitingNCT04069273
What this trial is testing

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Who this might be right for
Gastric CancerGastroEsophageal CancerAdenocarcinoma
Harry H Yoon 58
Early research (Phase 1)Ended earlyNCT06560645
What this trial is testing

PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Carcinoma+7 more
Prelude Therapeutics Incorporated 42
Testing effectiveness (Phase 2)Ended earlyNCT04683939
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Who this might be right for
Solid TumorGastric CancerGastroesophageal Junction Adenocarcinoma+5 more
BioNTech SE 13
Testing effectiveness (Phase 2)Ended earlyNCT00551759
What this trial is testing

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Eastern Cooperative Oncology Group 22
Testing effectiveness (Phase 2)Study completedNCT01217060
What this trial is testing

Trimodality Management of T1b Esophageal Cancers

Who this might be right for
Esophageal Cancer
M.D. Anderson Cancer Center 4
Large-scale testing (Phase 3)Study completedNCT02581462
What this trial is testing

FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer

Who this might be right for
Stomach CancerGastroesophageal Junction Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 81
Testing effectiveness (Phase 2)UnknownNCT02037048
What this trial is testing

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Gastric Cardia+3 more
Case Comprehensive Cancer Center 63
Testing effectiveness (Phase 2)Study completedNCT00711243
What this trial is testing

Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor

Who this might be right for
Gastric CancerUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University 59
Early research (Phase 1)Looking for participantsNCT07705035
What this trial is testing

DBC-664 in Adult Patients With Solid Tumors

Who this might be right for
Malignant Germ Cell TumorLung AdenocarcinomaGastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma+3 more
Duboce Biopharmaceuticals, Inc. 210
Not applicableNot Yet RecruitingNCT07692477
What this trial is testing

Molecular Characterization of Tumor-Microenvironment Interactions to Predict Drug Resistance in Gastric and GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma (Siewert II-III)
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 250
Testing effectiveness (Phase 2)Looking for participantsNCT06324357
What this trial is testing

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Who this might be right for
Metastatic Breast CancerMetastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Boehringer Ingelheim 768
Testing effectiveness (Phase 2)UnknownNCT05163483
What this trial is testing

Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer

Who this might be right for
Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
Ruihua Xu 87
Large-scale testing (Phase 3)Study completedNCT03802591
What this trial is testing

CS1001 in Subjects With Gastric Adenocarcinoma or Gastro-Esophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
CStone Pharmaceuticals 479
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585580
What this trial is testing

Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy

Who this might be right for
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Qilu Hospital of Shandong University 59
Testing effectiveness (Phase 2)Ended earlyNCT03122548
What this trial is testing

Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
Aduro Biotech, Inc. 5
Testing effectiveness (Phase 2)UnknownNCT04098796
What this trial is testing

PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaAFP
China Medical University, China 30
Testing effectiveness (Phase 2)Ended earlyNCT05567835
What this trial is testing

Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Baylor College of Medicine 3
Testing effectiveness (Phase 2)UnknownNCT05608785
What this trial is testing

Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes

Who this might be right for
Gastric CancerGastroesophageal-junction Cancer
Henan Cancer Hospital 45
Next Page